Fan, Mengqiang
Tong, Peijian
Yan, Li
Li, Ting
Ren, Jiadan
Huang, Jiefeng
Du, Wenxi
Zhou, Li
Shan, Letian
Funding for this research was provided by:
Zhejiang Provincial Key Research and Development Program (2021C03046)
Natural Science Foundation of China (82074464)
Natural Science Foundation of China (82274373)
Natural Science Foundation of China (82104890)
Natural Science Foundation of China (81973873)
Article History
Received: 7 February 2023
Accepted: 5 June 2023
First Online: 19 June 2023
Declarations
:
: The animal use and experiments were approved by the Medical Norms and Ethics Committee of Zhejiang Chinese Medical University (Ethical number: 20190506–14). The use of SF from kOA patients was approved by the Ethics Committee of the First Affiliated Hospital of Zhejiang Chinese Medical University (Ethical number: 2020-KL-151–01).
: Not applicable.
: The authors declare that they have no competing interests.